Pulsar-18 T3 Stent System
FDA premarket approval P160025/S013 · decided 2022-07-20
Approval details
- PMA number
- P160025
- Supplement
- S013
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Pulsar-18 T3 Stent System
- Generic name
- STENT, SUPERFICIAL FEMORAL ARTERY
- Applicant
- Biotronik AG
- Date received
- 2021-09-27
- Decision date
- 2022-07-20
- Days to decision
- 296 days
- Decision code
- APPR
- Product code
- NIP
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Bülach
- Statement
- Approval for the Pulsar-18 T3 Stent System, which incorporates an updated delivery system to the Pulsar-18 Stent System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| PHERON PERIPHERAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER (K052757) | Biotronik AG | 2005-10-28 |